DT Definium Therapeutics, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Definium Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €5.5bn. The latest transaction was filed on 4 September 2026 (Attribution). Among the most active insiders: Barrow Robert. All data is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Definium Therapeutics, Inc. Strong Buy (bullish), based on 17 analysts. Average price target: US$67.47.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 September 2026
All Executives37 Thresholds0 Prospectus0 Other0
Declarations 37 total
◆ Chief Executive Officer · Executives · 2 Sept 2026
40,000 shares 0Common Shares SEC:0001193125-26-384042:0
▼ Chief Executive Officer · Executives · 3 Sept 2026
19,023 shares @ US$37.94 0.013% mcap 61.6% of flow Common Shares SEC:0001193125-26-384042:1
● Officer, Director · Executives · 3 Sept 2026
19,023 shares @ US$37.7514 Common SEC144:0001950047-26-009064
◆ Chief Commercial Officer · Executives · 12 Aug 2026
62,500 shares 0Common Shares SEC:0001193125-26-345836:0
◆ Chief Legal Officer · Executives · 12 Aug 2026
62,500 shares 0Common Shares SEC:0001193125-26-345837:0
◆ Chief Medical Officer · Executives · 12 Aug 2026
100,000 shares 0Common Shares SEC:0001193125-26-345838:0
◆ Chief Executive Officer · Executives · 12 Aug 2026
375,000 shares 0Common Shares SEC:0001193125-26-345839:0
◆ Chief Financial Officer · Executives · 12 Aug 2026
62,500 shares 0Common Shares SEC:0001193125-26-345835:0
▼ Chief Executive Officer · Executives · 25 Jun 2026
29,208 shares Common Shares SEC:0001193125-26-285562:0
▼ Chief Commercial Officer · Executives · 25 Jun 2026
2,867 shares Common Shares SEC:0001193125-26-285558:0
▼ Chief Financial Officer · Executives · 25 Jun 2026
3,013 shares Common Shares SEC:0001193125-26-285563:0
▼ Chief Medical Officer · Executives · 25 Jun 2026
10,035 shares Common Shares SEC:0001193125-26-285564:0
▼ Chief Legal Officer · Executives · 25 Jun 2026
13,008 shares Common Shares SEC:0001193125-26-285567:0
● Officer, Director · Executives · 25 Jun 2026
29,208 shares @ US$42.13 100.0% of flow Common SEC144:0001950047-26-006487
● Officer · Executives · 25 Jun 2026
10,035 shares @ US$42.13 100.0% of flow Common SEC144:0001950047-26-006489
● Officer · Executives · 25 Jun 2026
3,013 shares @ US$42.13 100.0% of flow Common SEC144:0001950047-26-006491
● Officer · Executives · 25 Jun 2026
2,867 shares @ US$42.13 100.0% of flow Common SEC144:0001950047-26-006492
● Officer · Executives · 25 Jun 2026
13,008 shares @ US$42.13 100.0% of flow Common SEC144:0001950047-26-006493
◆ Chief Executive Officer · Executives · 22 Jun 2026
375,000 shares Common Shares SEC:0001193125-26-276882:0
◆ Chief Medical Officer · Executives · 22 Jun 2026
100,000 shares Common Shares SEC:0001193125-26-276878:0
◆ Chief Legal Officer · Executives · 22 Jun 2026
62,500 shares Common Shares SEC:0001193125-26-276879:0
◆ Chief Financial Officer · Executives · 22 Jun 2026
62,500 shares Common Shares SEC:0001193125-26-276880:0
◆ Chief Commercial Officer · Executives · 22 Jun 2026
62,500 shares Common Shares SEC:0001193125-26-276881:0
◆ Director · Executives · 11 Jun 2026
3,555 shares Common Shares SEC:0001193125-26-271155:0
◆ Director · Executives · 11 Jun 2026
4,666 shares Common Shares SEC:0001193125-26-271154:0
25 of 37 declarations
Load more (12 remaining) 关于 Definium Therapeutics, Inc. Definium Therapeutics, Inc. 是一家专注于开发治疗严重疾病的创新疗法的公司。该公司在 XNAS 市场上市。